JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) — Capital Reinvestment Ratio
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Capital Reinvestment Ratio of 13.41x as of December 2025, meaning it reinvests 13% of its operating cash flow ($341.55K) in capital expenditures ($4.58 Million). Check tangible net worth ratio of JIN MEDICAL INTERNATIONAL LTD. Ordinary to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Capital Reinvestment Ratio (2020–2025)
This chart tracks JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see ZJYL cash generation efficiency.
Annual Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)
Year-by-year Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2020 to 2025. See ZJYL free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | $2.90 Million | $6.63 Million | ▲ +6125.3% |
| 2023 | 0.04x | $3.11 Million | $113.94K | ▲ +44.3% |
| 2022 | 0.03x | $1.58 Million | $40.17K | ▲ +246.3% |
| 2021 | 0.01x | $5.84 Million | $42.88K | ▼ -87.1% |
| 2020 | 0.06x | $2.50 Million | $142.32K | — |